scholarly article | Q13442814 |
P356 | DOI | 10.1148/RADIOL.2017162204 |
P698 | PubMed publication ID | 29059037 |
P50 | author | Koji Sagiyama | Q84594174 |
Hidetake Yabuuchi | Q88410683 | ||
H Honda | Q88632968 | ||
Takeshi Kamitani | Q90840626 | ||
Yuzo Yamasaki | Q94485961 | ||
Satoshi Kawanami | Q114440698 | ||
P2093 | author name string | Isamu Okamoto | |
Eiji Iwama | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | bevacizumab | Q413299 |
non-small-cell lung carcinoma | Q3658562 | ||
P304 | page(s) | 685-695 | |
P577 | publication date | 2017-10-23 | |
P1433 | published in | Radiology | Q3285690 |
P1476 | title | Prediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups | |
P478 | volume | 286 |